How much does the SelectMDx test cost?
SelectMDx for prostate cancer is a non-invasive urine test. It measures the amount of two genes in urine that are associated with aggressive prostate cancer. This is combined with clinical information to assess the risk of having aggressive prostate cancer.
The SelectMDx test costs between 250 and 290 euro (excl. VAT) depending on the local circumstances of your country. As the SelectMDx test is new, it may not yet be covered by your health insurances. It will depend on your country and the type of health insurance. You can contact your health insurance for more information.
Read more about the available options in case of an elevated PSA.